0001415889-24-003984.txt : 20240215
0001415889-24-003984.hdr.sgml : 20240215
20240215181409
ACCESSION NUMBER: 0001415889-24-003984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patni Rajiv
CENTRAL INDEX KEY: 0001616200
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38890
FILM NUMBER: 24645216
MAIL ADDRESS:
STREET 1: C/O OCERA THERAPEUTICS, INC.
STREET 2: 525 UNIVERSITY AVENUE, SUITE 610
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quince Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662774
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 901024039
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 273
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-910-5717
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 273
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Cortexyme, Inc.
DATE OF NAME CHANGE: 20160104
4
1
form4-02152024_110201.xml
X0508
4
2024-02-15
0001662774
Quince Therapeutics, Inc.
QNCX
0001616200
Patni Rajiv
C/O QUINCE THERAPEUTICS, INC.
611 GATEWAY BOULEVARD, SUITE 273
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
0
Employee Stock Option (right to buy)
1.30
2024-02-15
4
A
0
54000
0
A
2034-02-15
Common Stock
54000
54000
D
The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of February 15, 2024, subject to the Reporting Person's continued service as a member of the Board of Directors of the Issuer as of each such vesting date.
/s/ Brendan Hannah, Attorney-in-Fact
2024-02-15